Adagene and ADC Therapeutics enter into an oncology antibody collaboration

800px-Antibody_IgG2
Both Adagene and ADC Therapeutics’ technology will be leverage to develop a proprietary antibody drug conjugate (ADC) against a solid tumour target. Credit: TimVickers at English Wikipedia.